Physician

Carlos Santivanez, M.D.

According to 2025 Medicare claims, Carlos Santivanez, M.D. (NPI: 1992767586) practices internal medicine in the Hanford-Corcoran, CA market, with the plurality of this provider's patient population coming from Kings, CA. This provider's primary affiliated billing organization is CARLOS SANTIVANEZ M.D., INC (NPI: 1770604787) and primary practice location at 93230-4314. Santivanez is affiliated with the Aledade 45 CA CHC MSSP Enhanced (ACO ID: A4542), participating under the MSSP model.

Santivanez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 234 traditional Medicare patients, billed 5,436 HCPCS/CPT codes, and received $204,406 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 16,154 prescription claims across 724 beneficiaries totaling $1,765,051 in drug costs, led by Jardiance (Empagliflozin). DME data shows 376 claims. Open Payments data shows 92 records totaling $2,140. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,316,361 to $1,765,051. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $94,640 to $38,444.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	409	11,800	$299,126
2016	379	9,028	$260,903
2017	359	10,099	$253,016
2018	339	10,544	$259,772
2019	294	6,952	$242,454
2020	265	3,879	$197,226
2021	232	8,131	$223,397
2022	211	9,334	$270,394
2023	223	7,083	$248,670
2024	234	5,436	$204,406

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	555	17,510	$1,316,361
2016	563	16,019	$1,255,903
2017	548	15,544	$1,125,990
2018	555	14,958	$1,047,230
2019	486	12,322	$1,048,497
2020	494	12,944	$1,183,581
2021	541	12,481	$1,284,287
2022	580	13,007	$1,291,803
2023	659	15,183	$1,878,187
2024	724	16,154	$1,765,051

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	263	1,162	$64,925
2016	236	897	$31,799
2017	177	750	$10,342
2018	163	698	$8,862
2019	127	710	$9,811
2020	98	646	$15,873
2021	76	531	$17,494
2022	78	414	$13,795
2023	69	487	$24,466
2024	59	376	$30,559

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93880	Ultrasound of both sides of head and neck blood flow	96	96	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	228	1,630	$84
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	96	96	$75
G0008	Administration of influenza virus vaccine	96	96	$33
90656	Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage	94	94	$22

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	213	9,810	$185,174
Ozempic	Semaglutide	157	4,525	$149,545
Trulicity	Dulaglutide	152	4,366	$143,004
Eliquis	Apixaban	111	4,590	$87,530
Mounjaro	Tirzepatide	77	2,160	$79,611

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	23	$11,238
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$10,227
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	53	$3,775
E1161	Manual adult size wheelchair, includes tilt in space	Y	N/R	12	$2,216
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	41	137	$1,474

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	92	$2,140	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carlos Santivanez, M.D.?

Tedicare shows public-source Medicare data for Carlos Santivanez, M.D. (NPI 1992767586), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carlos Santivanez, M.D. have ACO affiliation data?

Carlos Santivanez, M.D. is shown with ACO affiliation data for Aledade 45 CA CHC MSSP Enhanced (MSSP, ACO ID A4542).

What billing organization is linked to Carlos Santivanez, M.D.?

Carlos Santivanez, M.D. is linked to CARLOS SANTIVANEZ M.D., INC (billing NPI 1770604787) in the available physician profile data.

Does Carlos Santivanez, M.D. have Open Payments data?

Carlos Santivanez, M.D. has 92 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.